Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 2/2020

01-02-2020 | Systemic Sclerosis | Letter to the Editor

Response to the letter by Dr. Costa-Moreira, Dr. Peixoto, Dr. Ramalho, and Dr. Macedo regarding our manuscript: “Relationship between esophageal motility abnormalities and skin or lung involvements in patients with systemic sclerosis”

Authors: Shiko Kuribayashi, Sei-ichiro Motegi, Kenichiro Hara, Akiko Sekiguchi, Hiroko Hosaka, Motoyasu Kusano, Toshio Uraoka

Published in: Journal of Gastroenterology | Issue 2/2020

Login to get access

Excerpt

Dear editor …
Literature
1.
Richardson C, Agrawal R, Lee J, et al. Esophageal dilatation and interstitial lung disease in systemic sclerosis: a cross-sectional study. Semin Arthritis Rheum. 2016;46:109–14.CrossRef
2.
Takekoshi D, Arami S, Sheppard TJ, et al. Computed tomography of the esophagus in scleroderma and lung disease. Tohoku J Exp Med. 2015;237:345–52.CrossRef
3.
Marie I, Dominique S, Levesque H, et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum. 2001;45:346–54.CrossRef
4.
Savarino E, Bazzica M, Zentilin P, et al. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med. 2009;179:408–13.CrossRef
5.
Gilson M, Zerkak D, Wipff J, et al. Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases. Eur Respir J. 2010;35:112–7.CrossRef
Metadata
Title
Response to the letter by Dr. Costa-Moreira, Dr. Peixoto, Dr. Ramalho, and Dr. Macedo regarding our manuscript: “Relationship between esophageal motility abnormalities and skin or lung involvements in patients with systemic sclerosis”
Authors
Shiko Kuribayashi
Sei-ichiro Motegi
Kenichiro Hara
Akiko Sekiguchi
Hiroko Hosaka
Motoyasu Kusano
Toshio Uraoka
Publication date
01-02-2020
Publisher
Springer Singapore
Published in
Journal of Gastroenterology / Issue 2/2020
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-019-01630-5

Other articles of this Issue 2/2020

Journal of Gastroenterology 2/2020 Go to the issue

Original Article—Alimentary Tract

Short-term safety and efficacy of peroral endoscopic myotomy for the treatment of achalasia in children

Original Article—Liver, Pancreas, and Biliary Tract

Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients

Review

Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives

Original Article—Liver, Pancreas, and Biliary Tract

Insulin secretion improvement during steroid therapy for autoimmune pancreatitis according to the onset of diabetes mellitus

Review

Efficacy of enteral nutrition in patients with Crohn’s disease on maintenance anti-TNF-alpha antibody therapy: a meta-analysis

Letter to the Editor

Relationship between esophageal manometry and pulmonary function tests in patients with systemic sclerosis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits